Cyfuse Biomedical KK (TSE:4892) Ending Cash Position : 円0.00 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK Ending Cash Position?

Cyfuse Biomedical KK's Ending Cash Position for the quarter that ended in Dec. 2023 was 円0.00 Mil.

Cyfuse Biomedical KK's annual Ending Cash Position increased from Dec. 2021 (円1,613.04 Mil) to Dec. 2022 (円3,437.31 Mil) but then declined from Dec. 2022 (円3,437.31 Mil) to Dec. 2023 (円2,873.77 Mil).

Cyfuse Biomedical KK Ending Cash Position Historical Data

The historical data trend for Cyfuse Biomedical KK's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK Ending Cash Position Chart

Cyfuse Biomedical KK Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

1,272.88

1,613.04

3,437.31

2,873.77

Cyfuse Biomedical KK Quarterly Data
	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial				-	-	-	-	-

Cyfuse Biomedical KK Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Cyfuse Biomedical KK's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3437.307	+	-563.534
	=	2,873.77

Cyfuse Biomedical KK's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0.00

Cyfuse Biomedical KK Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyfuse Biomedical KK (TSE:4892) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN

Website

https://www.cyfusebio.com

Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK (TSE:4892) Headlines

No Headlines